CoQ10 oxidoreductases in ferroptosis and cancer: redox regulation and therapeutic opportunities

Read full text
Authors: Jumi Lee, Inhwan Yoo, Minseok Kim, Hyeonseok Kim, Namgyu Lee
Cited by: 4
References: 112

Abstract

Abstract Coenzyme Q 10 (CoQ 10 ) is a highly conserved lipophilic redox cofactor that mediates electron transport in mitochondria and protects cells against oxidative stress. Increasing evidence has revealed that CoQ 10 and its associated oxidoreductases serve as critical regulators of ferroptosis—an iron-dependent, lipid peroxidation-driven form of cell death. Here we provide an updated overview of the canonical CoQ 10 biosynthetic pathway and the established functions of key CoQ 10 oxidoreductases. We highlight emerging insights into ferroptosis-suppressive roles of enzymes such as FSP1, DHODH and SQOR, which act by regenerating ubiquinol (CoQ 10 H 2 , reduced). In addition, we discuss newly identified CoQ 10 -related enzymes and their mechanistic contributions to ferroptosis regulation. By integrating perspectives from biochemistry, metabolism and cancer biology, this review positions CoQ 10 oxidoreductases as promising targets for ferroptosis-based cancer therapies.

Fields of Study & Subjects

Coenzyme Q10 studies and effects Ferroptosis and cancer prognosis Metalloenzymes and iron-sulfur proteins

Publication details

Journal / source
Experimental & Molecular Medicine
Publisher
Springer Science and Business Media LLC
Volume
58
Issue
6
Pages
1699–1710
Publication date
3 June 2026
Language
EN